Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

被引:51
|
作者
Koh, Ye Xin [1 ]
Tan, Hiang Jin [1 ]
Liew, Yi Xin [2 ]
Syn, Nicholas [1 ]
Teo, Jin Yao [1 ,4 ]
Lee, Ser Yee [1 ,4 ]
Goh, Brian K. P. [1 ,4 ]
Goh, George B. B. [3 ,4 ]
Chan, Chung Yip [1 ,4 ]
机构
[1] Singapore Gen Hosp, Dept Hepatopancreatobiliary & Transplant Surg, 20 Coll Rd, Singapore 169856, Singapore
[2] Singapore Gen Hosp, Dept Pharm, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[4] Duke Natl Univ Singapore, Singapore, Singapore
关键词
NAFLD; STEATOHEPATITIS; SURVIVAL;
D O I
10.1016/j.jamcollsurg.2019.07.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC) is on the rise worldwide, but data on long-term outcomes after curative operations are limited. The primary aim of this study was to characterize the perioperative and long-term outcomes after liver resection. The secondary aim was to investigate the influence of the histologic severity of nonalcoholic steatohepatitis and its impact on perioperative outcomes and long-term survival. METHODS: A total of 996 patients who underwent liver resection for HCC in our institution were analyzed. Patients were categorized into subgroups of NAFLD vs non-NAFLD HCC based on histologic evidence of hepatic steatosis. Comparisons of patients' demographic, clinical, and surgical characteristics; postoperative complications; and survival outcomes were performed. RESULTS: Eight hundred and forty-four patients had non-NAFLD HCC and 152 patients had NAFLD HCC. Comorbidities were significantly more common in the NAFLD group (p < 0.0001). In the non-NAFLD group, larger median tumor size, higher liver cirrhosis, and lower median neutrophil to lymphocyte ratio were observed (p < 0.0001). The NAFLD group had a greater amount of intraoperative blood loss, more postoperative complications, and longer length of stay. Five-year overall survival was significantly better in the NAFLD group (p = 0.0355). Significant factors that contribute to poorer survival outcomes include age, congestive cardiac failure, Child-Pugh's class B, cirrhosis, tumor size, multinodularity, and R1 resection. For NAFLD group, patients with abnormal parenchyma showed poorer survival and 5-year overall survival rates (64.8% vs 75.6%; p = 0.2291). CONCLUSIONS: Nonalcoholic fatty liver disease-related HCC is associated with greater surgical morbidity and post-hepatectomy liver failure. Despite this, long-term survival outcomes are favorable compared with non-NAFLD etiologies. ((C) 2019 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)
引用
收藏
页码:467 / +
页数:13
相关论文
共 50 条
  • [1] Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma
    Duan, Xiao-Yan
    Qiao, Liang
    Fan, Jian-Gao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (01) : 18 - 27
  • [2] Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma
    Xiao-Yan Duan
    Storr Liver Unit at the Westmead Millennium Institute
    Hepatobiliary & Pancreatic Diseases International, 2012, 11 (01) : 18 - 27
  • [3] Outcomes after laparoscopic or open liver resection for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: a propensity score-matching study
    Watanabe, Yukihiro
    Aikawa, Masayasu
    Oshima, Yuhei
    Kato, Tomotaka
    Takase, Kenichiro
    Watanabe, Yuichiro
    Okada, Katsuya
    Okamoto, Kojun
    Koyama, Isamu
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2024, 38 (07): : 3887 - 3904
  • [4] Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in the United States
    Karim, Mohammad A.
    Singal, Amit G.
    Kum, Hye Chung
    Lee, Yi-Te
    Park, Sulki
    Rich, Nicole E.
    Noureddin, Mazen
    Yang, Ju Dong
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (03) : 670 - +
  • [5] Nonalcoholic fatty liver disease and hepatocellular carcinoma
    Zoller, Heinz
    Tilg, Herbert
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1151 - 1160
  • [6] Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Inayat, Faisal
    Rahman, Zia Ur
    Hurairah, Abu
    CUREUS, 2016, 8 (08):
  • [7] Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Zhao, Lei
    Dong, Fei
    Tsai, Harrison
    Hornick, Jason
    Goyal, Lipika
    Hashemi, Nikroo
    Corey, Kathleen
    Misdraji, Joseph
    MODERN PATHOLOGY, 2019, 32
  • [8] Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
    Kikuchi, Luciana
    Oliveira, Claudia P.
    Carrilho, Flair J.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [9] Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Zhao, Lei
    Dong, Fei
    Tsai, Harrison
    Hornick, Jason
    Goyal, Lipika
    Hashemi, Nikroo
    Corey, Kathleen
    Misdraji, Joseph
    LABORATORY INVESTIGATION, 2019, 99
  • [10] DISTINCT HEPATIC IMMUNOLOGICAL PATTERNS ARE ASSOCIATED WITH THE PROGRESSION OR INHIBITION OF NONALCOHOLIC FATTY LIVER DISEASE-ASSOCIATED HEPATOCELLULAR CARCINOMA
    Isbell, Madison
    HEPATOLOGY, 2022, 76 : S621 - S621